Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Claudio Tatsui

Neurological Surgery Houston, TX Medical Doctor

NPI 1013178425 CMS profile 562649

1515 Holcombe Blvd, Department Of Neurosurgery -Unit 442, Houston, TX 77030

Open in the dashboard

General payments

$82,446

132 records reported · program years 2019–2025

Research payments

$2,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$694,332 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Claudio Tatsui of Houston, TX is reported in the CMS Open Payments database as having received $82,446 across 132 general payments and $2,000 in research payments paid to them. Separately, studies naming them as principal investigator received $694,332 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,722 35
2024 General $8,826 19
2023 General $4,997 14
2022 General $3,266 7
2021 General $3,214 4
2021 Research $2,000 1
2020 General $19,540 19
2019 General $21,881 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Claudio Tatsui
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Claudio Tatsui were reported at $20,722. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Claudio Tatsui Neurological Surgery median Middle half National median
2019 $21,881 $582 $138–$3,006 $163
2020 $19,540 $294 $76–$2,174 $114
2021 $3,214 $387 $105–$2,432 $132
2022 $3,266 $542 $139–$2,989 $149
2023 $4,997 $534 $145–$2,697 $160
2024 $8,826 $574 $155–$3,046 $164
2025 $20,722 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. icotec Medical Inc. $42,325 71 payments
  2. Medical Device Business Services, Inc. $35,762 25 payments
  3. Medtronic USA, Inc. $1,857 14 payments
  4. Novocure Inc. $661 3 payments
  5. Stryker Corporation $576 7 payments
  6. Kuros Biosciences USA, Inc $395 2 payments
  7. Sanara MedTech Inc. $343 2 payments
  8. Carbofix Spine Inc $217 1 payment
  9. DePuy Synthes Sales Inc. $164 4 payments
  10. Prosidyan, Inc $103 1 payment
  11. Other $45 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $68,164 15 payments
  2. Travel and Lodging $8,211 35 payments
  3. Food and Beverage $6,072 82 payments
Products named General payments · program years 2019–2025
  1. VIPER $30,543 25 payments
  2. CONCORDE $28,712 14 payments
  3. COUGAR $27,523 5 payments
  4. ViviGen $27,523 5 payments
  5. KONG-TL VBR E, EXPANDABLE BODY, L, 19 MM X 27 - 37 MM $19,089 25 payments
  6. VADER PEDICLE SYSTEM, ROD, CARBON/PEEK, CURVED, 6.0 R450 X 200 MM $19,089 25 payments
  7. KONG-TL VBR, END PLATE, RECTANGULAR, M AND SCREW, 12 X 33 MM $19,089 25 payments
  8. KONG-TL VBR, END PLATE, ROUND, L AND SCREW, 12 X 43 MM $19,089 25 payments
  9. VADER PEDICLE SYSTEM 6.0, SCREW, CARBON/PEEK, POLYAX., FEN., O 5.5 X 45 MM $19,089 25 payments
  10. icotec BlackArmor Spine System $8,826 19 payments
  11. Other $41,796 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. GT Medical Technologies, Inc $2,000 1 payment

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$100,125

Medicare's payments for the services billed

Medicare patients

63

Average age 72

Services billed

229

27 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Cancer 49%
Ischemic heart disease 38%
Osteoporosis 37%
Diabetes 30%
Chronic kidney disease 30%
Depression 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record